ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1745

Memory Stem T Cells Are Selectively Enriched in Patients with Rheumatoid Arthritis, Contract upon Anti-TNF Treatment, and May Provide a Long-Term Reservoir of Arthritogenic Lymphocytes

Nicoletta Cieri1, Giacomo Oliveira1, Raffaella Greco2, Mattia Baldini3, Elena Baldissera4, Fabio Ciceri2 and Chiara Bonini1, 1Division of Immunology, Infectious Diseases and Transplants, Experimental Hematology Unit, San Raffaele Scientific Institute, Milan, Italy, 2Division of Regenerative Medicine, Gene Therapy and Stem Cells, Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy, 3Division of Immunology, Infectious Diseases and Transplants, Clinical immunopathology and advanced medical therapeutics, San Raffaele Scientific Institute, Milan, Italy, 4Clinical immunopathology and advanced medical therapeutics, San Raffaele Scientific Institute, Milan, Italy

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: lymphocytes and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: T cell Biology in Rheumatoid Arthritis and Other Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: the T-cell memory compartment is multi-faceted and encompasses multiple subsets with divergent properties. In addition to central memory (TCM) and effector memory (TEM) cells, the spectrum of immunological memory has been recently extended with the identification of memory stem T cells (TSCM). Gene expression profiling, corroborated by in vitro and in vivo experimental results, posits TSCM upstream TCM and TEM in T-cell ontology (Gattinoni, Nat Med 2011; Cieri, Blood 2013). While self-renewing TSCM would be highly desirable if bearing protective specificities, this very same cell subpopulation may also represent a foe when considering T-cell mediated pathologies. We hypothesized that, in these clinically relevant contexts, TSCM may represent a reservoir of long-lived T cells with undesired and detrimental specificities responsible for disease perpetuation. 

Methods: we characterized TSCM dynamics in 15 patients with active rheumatoid arthritis (RA) and upon treatment with etanercept (median time from anti-TNF treatment onset: 3 months). T-cell subset composition and function was evaluated by 11-colors multiparametric flow cytometry.

Results: we found that TSCM cells, defined as CD45RA+CD62L+CD95+, are significantly more represented in terms of frequencies and absolute counts in patients with active RA as compared to age- and sex-matched healthy controls. Of notice, the extent of TSCM expansion correlated with disease severity (quantified by DAS28 score), suggesting an active role of TSCM in disease pathophysiology. Functionally, expanded CD4+ TSCM displayed a preferential TH17 polarization, known to have a fundamental pathogenic role in rheumatic synovitis, and thus further corroborating TSCM lymphocytes as a potential novel player in RA pathogenesis and perpetuation. Importantly, TNF-a neutralization, upon etanercept administration, efficiently reduced the frequency and number of circulating TSCM and restored T-cell homeostasis in responder patients. Prior to etanercept treatment, TSCM lymphocytes expressed TNFR2 to significantly higher levels compared to the other T-cell subsets both in CD4+ and CD8+ compartments, suggesting that TNF-a might act as a costimulatory signal for TSCM lymphocytes in the context of RA. Finally, ongoing experiments will elucidate whether TSCM accumulation is due to the selective expansion of arthritogenic clones through the characterization of the TCR repertoire and antigen-specificities of TSCM cells from RA patients. 

Conclusion: understanding the dynamic and quantitative aspects of TSCM lymphocyte behavior in RA will have profound implications for devising strategies to counteract T-cell dysfunction in RA patients.


Disclosure:

N. Cieri,
None;

G. Oliveira,
None;

R. Greco,
None;

M. Baldini,
None;

E. Baldissera,
None;

F. Ciceri,
None;

C. Bonini,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/memory-stem-t-cells-are-selectively-enriched-in-patients-with-rheumatoid-arthritis-contract-upon-anti-tnf-treatment-and-may-provide-a-long-term-reservoir-of-arthritogenic-lymphocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology